MET and neoplasm: The hepatocyte growth factor receptor MET has pleiotropic effects on proliferation, survival, motility, and angiogenesis, but also drives EMT and tumor invasion.129 Studies on MET-positive GCs report a prevalence ranging from 3.8 to 85%, with variability due to different antibodies and scoring systems.130 Various strategies targeting MET were tested, however with minor success.